INTRODUCTION
Development of the head and face comprises one of the most complex events during embryonic development, coordinated by a network of transcription factors and signalling molecules together with proteins conferring cell polarity and cell-cell interactions. Disturbance of this tightly controlled cascade can result in a facial cleft where the facial primordia ultimately fail to meet and fuse or form the appropriate structures. Collectively, craniofacial abnormalities are among the most common features of all birth defects. The most frequent of these are the orofacial clefts, cleft lip and/or cleft palate (CL/P). CL/P results in complications affecting feeding, speech, hearing and psychological development. Patients will undergo multiple rounds of surgical repair starting in the first year of life and may continue until 18 or 20 years old. Frequently, extensive dental and orthodontic treatment, speech and hearing therapy may be required as well as referral for psychotherapy and genetic counselling. Occurrence estimates range between 1/300 and 1/2500 births for cleft lip with or without cleft palate (CLP) and around 1/1500 births for cleft palate alone (CP) (1) . It has been reported that CLP occurs more frequently in males, while the sex bias is reversed for CP, which is more common in females (2) . Approximately 50% of CL patients also have CP, which is thought to be a secondary effect resulting from the defect in facial prominence fusion that precedes palate formation. CP occurring alone is therefore considered to be etiologically distinct from CLP. The majority of CL/P ($70%) are regarded as nonsyndromic, where the clefts occur without other anomalies. The remaining syndromic cases have additional characteristic features that can be subdivided into categories of chromosomal abnormalities, recognizable Mendelian single gene syndromes, teratogenic effects and various unknown syndromes.
The high familial aggregation rates, recurrence risks and elevated concordance rates in monozygous versus dizygous twins provide evidence for a strong genetic component in CL/P (3). Despite this, familial inheritance is complex with simple Mendelian inheritance considered uncommon. As a general model, it is thought that both genes and environmental factors, acting either independently or in combination, are responsible (4) , much effort has been concentrated on identifying the genetic contribution. This has taken the form of direct analysis of candidate genes, association studies with candidate genes or loci and genome-wide scans using large collections of CL/P families. Many mouse mutants with isolated clefts have been described where the specific gene is known (5) , and these too contribute to the pool of candidate genes. We can therefore confidently predict that many individual genes, acting either alone or within gene networks, will be responsible for the heterogeneous causality observed in humans. It has been predicted that CLP would best fit an oligogenic model where one or a few major genes were influenced by a small number of modifiers (3, (6) (7) (8) . Nevertheless, the intense efforts of current screening programmes have not revealed major risk factors for human clefting, and the identification of causative mutations has remained elusive. This general failure probably reflects a more complicated and diverse etiology than these studies suggested. It is therefore encouraging that several important risk factors have recently been identified directly from human analyses. Interestingly, this has been achieved using syndromic CL/P patients, where the additional phenotypic features have allowed patients to be subdivided into more homogeneous and readily analysable groups.
EMBRYONIC DEVELOPMENT
Development of the human face begins in the fourth week of gestation when migrating neural crest cells from the dorsal region of the anterior neural tube (cranial neural crest, CNC) combine with mesodermal cells to establish the facial primordia. The maxillary prominences enlarge and grow towards each other and the nasal prominences. During the sixth to seventh weeks, the nasal prominences merge to form the intermaxillary segment resulting in both the filtrum and primary palate. This region then fuses to the maxillary prominences, which form the lateral parts of the upper lip (9) . The secondary palate is also CNC derived and forms the palatal shelves, which grow out from the maxillary prominences. Mouse mutants with disruption in genes such as Gli2, Gli3, Tgfb2 and Hoxa2 result in CL/P through disturbance to CNC migration and differentiation (10) (11) (12) .
In the mouse the palatal shelves first appear at around E12.5 (approximately 6 weeks post conception in human) and rapidly grow in a vertical plane flanking the developing tongue (Fig. 1) . A key stage in mouse palatogenesis occurs during E12.5-E13.5, when the shelves, consisting of rapidly proliferating mesenchymal cells, undergo a sudden elevation to bring them into horizontal apposition above the flattening tongue. Several genes have been implicated in palatal mesenchymal proliferation such as Msx1 and Lhx8, where CP is seen in the respective null mice due to the palatal shelves failing to meet in the horizontal plane (13, 14) . As a general model, insufficient mesenchyme is believed to be the most common reason for CP in mice (5) .
Although several theories exist for how the palatal shelves elevate, the actual mechanisms responsible are unclear.
Movement from the vertical to the horizontal is likely to be a consequence of an intrinsic force resulting from increased turgidity through recruitment of water in response to elevated levels of glycosaminoglycans such as hyaluronan (15) . This occurs concomitantly with rapid remodelling of the extracellular matrix (ECM) (16) . The shelves require the ability to hinge and maintenance of the appropriate structural shape is important during changes to the ECM and proliferating mesenchyme. Pax9 mutant mice, for example, exhibit CP due to an abnormal morphology of the palatal shelves. The shelves are shorter and broader than the wild-type, which causes mechanical inhibition of shelf reorientation (17) . Following elevation, the medial edge epithelia (MEE) of the opposing palatine shelves fuse in the midline through interactions of cell adhesion molecules and desmosomes. The palatal shelves initially contact in the mid portion and then zipper closed towards both the primary palate and the uvula. The resulting epithelial seam is rapidly removed through a combination of programmed cell death, epithelial cell migration and transdifferentiation (18, 19) . Palatogenesis is considered to be complete in mouse by around E15.5 or 12 weeks in the human.
DEVELOPMENTAL GENE NETWORKS
A variety of molecules have been implicated in signalling facial primordia identity, epithelial differentiation and shelf remodelling (Table 1) . These include ECM molecules and growth factors, which act as inductive signals such as sonic hedgehog (Shh), bone morphogenetic proteins (Bmp), fibroblast growth factors (Fgf) and members of the transforming growth factor b (Tgfb) superfamily. Shh plays an important role in the early induction of facial primordia in addition to expression in the palatal MEE (20) . Bmp2 and Bmp4 on the other hand, are expressed more specifically within the epithelia and mesenchyme of the palatal shelves. The Msx1 homeobox gene, which is also expressed in the facial primordia, is required for expression of Bmp2 and Bmp4 in the palatal mesenchyme and Shh in the MEE (21) . Epidermal growth factor (Egf) stimulates glycosaminoglycan production within the palatal shelves while Tgfa, expressed throughout the palatal mesenchyme and epithelia, stimulates extracellular matrix biosynthesis (22) . Fibronectin and collagen III act as modulating factors on hyaluronate expansion during shelf reorientation while collagen IX plays a critical role in signalling epithelialmesenchymal interactions, appearing in the MEE cell surface just prior to shelf elevation (23) . Transcription factors such as the distal-less (Dlx), Hox, Gli and T-box families also play key roles in maxillary and mandibular specification and are regulated by Shh, Bmps and Fgf signals (24) . Clearly epithelial-mesenchymal interactions are crucial in craniofacial development and specific sites of expression such as the tooth buds may function as inductive signalling centres influencing palate morphogenesis.
The Tgfb family is particularly interesting in palate development and isoforms 1, 2 and 3 are all expressed during this process. Recent evidence suggests that their function in the embryonic palate is at least in part mediated through the Smad signalling system (25) . Tgfb3 is expressed earliest and is found in the epithelial component of the vertical shelves. It is also
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Human Molecular Genetics, 2004, Vol. 13, Review Issue 1 expressed later in the horizontal shelves and MEE, but expression is undetected once the epithelial seam disrupts. Tgfb1 expression is limited to the horizontal shelves but like Tgfb3, switches off soon after epithelial seam disruption. While Tgfb1 and 2 accelerate palatal shelf fusion (26) , Tgfb3 may play a role in growth inhibition and is crucial for the first adhesive interaction. Indeed the Tgfb3 knock out mouse exhibits an isolated CP through failure of palatal shelf fusion (27, 28) . Although the palatal shelves otherwise develop normally, they show a marked reduction in the filopodia present on the MEE surface (29, 30) and show down-regulation of condroitin sulphate proteoglycan on the apical surface of the MEE (31) . Both of these are required for efficient MEE adhesion. In the mouse, antisense oligos, isoform-specific antibodies and gene knockouts show that palatal shelf fusion fails in the absence of Tgfb3 but not Tgfb1 or 2 (32) . Tissue remodelling during palatal fusion involves a combination of basement membrane degradation and epithelio-mesenchymal transformation, both of which are under the control of specific matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs). In the Tgfb3 À/À mouse, the palatal expression levels of Timp-2 and Mmp-13 are markedly reduced and their expression is dependent on Tgfb3 (33). This model shows that proteolytic degradation of the ECM is essential for palatal fusion. Overall it is clear that tight control of a cascade of genes is required to complete normal palatogenesis.
GENETIC ANALYSIS OF CL/P
Craniofacial development is highly complex with a large array of genes implicated. Combined with multigenic inheritance and the influence of non-genetic factors, identifying the key genes in human CL/P represents a major challenge. In addition to the direct analysis of functional candidates, much effort has gone into linkage and/or candidate gene directed association studies. A major drawback lies in the analysis of patients with heterogeneous etiology, since this dilutes the chances of finding positive gene-phenotype correlations. To date four genomewide scans for CL/P have been published, one using sib pair analysis in an English population (34), one using multiplex families of Chinese origin (35) , one using multiplex families from North and South America (36) and the other using two large Syrian families (37) . The four studies do not generally concur on significant or highly suggestive regions, probably reflecting the diverse populations investigated. An exception to this is a region on 2q, which overlaps between the Chinese study and a subset of the American families. A number of new genome scans have been presented at the American Society of Human Genetics 2003 meeting, including a meta-analysis totalling 11 studies (38) . Some regions consistent with previous linkage or candidate gene association studies (39) have been highlighted such as 2p13 (TGFA), 6p21.3-21.1, 17q12 (RARA), 1q22.3-41 (IRF6), and 2q35-36, as well as several new regions including, 7p13-15, 7q22-qter and 12q24-qter. It is hoped that this coordinated effort will provide the necessary power to fine map and identify the major genetic CL/P candidates.
Syndromic models for non-syndromic CL/P
Recently, positional cloning has been successful for several forms of syndromic CL/P either where rare large Mendelian families were available or where specific associated features allowed refinement of the study population. This produces a higher chance of identifying single gene causation. While these subgroups are referred to as syndromic clefts, it is now becoming apparent that the same genes contribute to the population of non-syndromic clefts, perhaps through variable penetrance or the action of different modifiers.
TBX22
We have been specifically interested in the X-linked Mendelian inherited form of CP (CPX), who exhibit a high degree of penetrance. This has been extensively studied as a rare but strongly genetic influence for nonsyndromic CP (40) (41) (42) (43) (44) (45) (46) (47) (48) (49) . In addition to CP or in some cases bifid or absent uvula, the majority of these patients also display ankyloglossia (tonguetie). This minor feature is frequently missed or unreported; however, when noted in addition to X-linked inheritance, it is an important diagnostic marker for CPX. Positional cloning identified the CPX locus as the gene encoding T-BOX 22 (TBX22) (50) . TBX22 is a recently described member of the T-box containing transcription factor gene family that is conserved throughout metazoan evolution. These genes play essential roles in early development and in particular mesoderm specification. The first T-box gene, Brachyury or T, was originally identified in mice (51) , where heterozygous animals have short tails and homozygotes lack a notochord and mesoderm posterior to somite 7 (52). Subsequently, a family of T-box proteins have been described including 18 in humans, all characterized by a similar DNA binding domain. In addition to TBX22, several other T-box genes have been implicated in human syndromes, emphasizing their importance in development. For example, haploinsuficiency of TBX3 or TBX5 causes ulnar-mammary and Holt-Oram syndromes respectively (53,54); TBX1 is deleted in DiGeorge syndrome (55, 56) ; and TBX19 is mutated in isolated ACTH deficiency (57) .
Although no gene deletions have yet been described for TBX22, a variety of point mutations have been identified. These include nonsense, splice site, frameshift and missense changes, with the latter affecting highly conserved residues within the T-box DNA-binding domain (58) . It is interesting to note that the G118C missense mutation found in a Canadian CPX family (50, 59 ) is at the equivalent position within the T-box domain to the G80R change seen in a Holt-Oram syndrome patient (60) . This position is predicted to interact with the major groove of target DNA and has been demonstrated to result in loss of DNA binding (61, 62) . Taken together with the X-chromosomal localization, CP in males is likely to result from complete loss of TBX22 function, while haploinsufficient females frequently exhibit a milder phenotype.
In addition to families with clear X-linked inheritance, mutations were also found in smaller families where ankyloglossia is a diagnostic feature (50, 63) . TBX22 expression correlates precisely with the phenotype seen in CPX patients, both in the vertical palatal shelves and the base of the tongue corresponding to the frenulum (63) . A similar expression pattern is seen in mouse (63, 64) and in chick (65) . The latter is interesting since birds have a constitutional cleft and one could speculate that Tbx22 expression is important in palatal shelf outgrowth rather than fusion. Despite the frequent concordance of CP and ankyloglossia in CPX patients, the phenotype can vary even within single families (Fig. 2) . Males usually have both CP and ankyloglossia (CPA) but occasionally CP (17%) or ankyloglossia (4%) alone. Female carriers may vary from fully affected to being phenotypically normal (CPA ¼ 11%, CP ¼ 6%, A ¼ 43%, unaffected ¼ 40%). A recent study of unselected Brazilian and North American CP patients, ascertained without bias for inheritance or ankyloglossia, showed that up to 4% resulted from TBX22 mutations (58). These include several sporadic patients with no ankyloglossia and a patient with isolated CP but with ankyloglossia only seen in the extended family. Furthermore, we have recently identified a DNA binding domain missense mutation in a five generation CP family with no evidence of ankyloglossia (unpublished data). This demonstrates that TBX22 (and therefore CPX) plays a more important role in the combined incidence of nonsyndromic CP than previously expected.
PVRL1
Autosomal recessive CLP with ectodermal dysplasia (CLPED1) is generally rare but occurs with a much higher frequency on Margarita Island (north of Venezuela). Positional cloning mapped the locus to 11q23 and mutations were identified in the cell adhesion molecule PVRL1 (Nectin-1), which is expressed in the developing face and palate (66) . On Margarita Island, CLPED1 is generally caused by homozygosity of the nonsense mutation W185X, while heterozygosity is high in the unaffected population. It has been speculated that, since Nectin-1 is the principle cell surface receptor for a-herpes viruses, the high frequency of heterozygotes might have resulted from relative resistance to infection by viruses such as HSV1 and HSV2 (67, 68) . The same mutation is also present on the Venezuelan mainland, where heterozygosity was found to be a significant risk factor for non-syndromic CLP (69) . It will be important to investigate whether PVRL1 mutations contribute to non-syndromic clefts in other geographical locations.
IRF6
Van der Woude syndrome (VWS) provides one of the best models for non-syndromic CLP since most patients have only minor additional phenotypes of lip pits and occasional hypodontia, while 15% have isolated CL/P. Linkage analysis localized the gene to 1q32-41 and mutations were identified in the interferon regulatory factor 6 gene IRF6 (70). In the mouse, Irf6 expression is restricted to the palatal MEE immediately prior to and during fusion. This markedly overlaps with the site of Tgfb3 expression and may suggest a potential interaction. A common IRF6 variant (V274I) within the protein binding domain was identified in the VWS studies and has since been evaluated as a potential modifier in isolated CL/P. Transmission disequilibrium testing of >8000 individuals from 10 different populations for V274I and additional SNPs in the vicinity, shows strong evidence that IRF6 is a modifier of CLP (71) . Whilst sequence analysis in this cohort has not yet identified changes with clear causative function, a second reported study has identified an IRF6 missense mutation in a two-generation apparently non-syndromic CLP family (72) .
P63
EEC syndrome is an autosomal dominant disorder of ectrodactyly, ectodermal dysplasia and CL/P. EEC syndrome was mapped to 3q27 and heterozygous mutations were identified in the p63 gene (73) . One unusual phenomenon with p63 is that mutation to different parts of the gene can influence the cleft phenotype. Missense mutation of the conserved DNA binding domain region gives CLP while C-terminal mutations give CL or CP. Mutation at the N-terminal end outside of the conserved domains gives rise to CP or no clefting at all. Only a small number of non-syndromic CL/P patients have been screened for mutations to date and no mutations have been found (74) . Not only is a larger study warranted but further investigation of downstream targets might be revealing. In particular Jagged2, a ligand in the notch signalling pathway, is known to act downstream of p63 and homozygous mouse knockouts of Jagged2 exhibit CP (75) .
MSX1
MSX1 first came to prominence as a candidate for CL/P following the generation of a gene knockout with cleft palate and oligodontia (13) . A candidate gene-based association study reported significant linkage disequilibrium between both CLP and CP with polymorphisms in MSX1 (76). In the same report, a cohort of non-syndromic CL/P patients were analysed for coding region mutations without success. An MSX1 mutation was reported in a Dutch family with tooth agenesis and a mixture of CLP and CP, providing another rare example of where a single gene, and in this case single mutation, can give rise to a mixed clefting phenotype (77) . Subsequently, conflicting reports have been published, some with evidence of linkage or association to either CLP or CP (78) (79) (80) (81) and some with no association to either (82, 83) . Despite these conflicts, which may arise due to variations caused by ethnic population differences, the strongest evidence for a role of MSX1 in CL/P has now been obtained by direct sequencing. Jezewski et al. (84) analysed a large cohort of CL/P patients from a variety of different ethnic origins and demonstrated that up to 2% of patients, predominantly with CLP, carried MSX1 mutations.
Other genes . . .
A variety of other genes causing syndromic CL/P are currently being analysed in extended cohorts as candidates for nonsyndromic clefting. Examples of these include FGFR1, where mutations result in autosomal recessive Kallmann syndrome (85) . As well as the characteristic hypogonadotropic hypogonadism and anosmia, five of the 13 patients with mutations had clefts of the lip or palate. Several forkhead genes represent good candidates, not only because of their craniofacial expression pattern but also because mutations give rise to clefts, e.g. TTF-2 mutations cause thyroid abnormalities and CP (86) , while FOXC2 mutations lead to distichiasis, lymphoedema and cleft palate (87) . In addition, two genes have recently been identified through chromosome rearrangements in cleft patients. These are the putative transcription factor SATB2 on 2q32-q33, which is disrupted in two unrelated patients with non-syndromic CP (88) and a novel acyl-CoA desaturase ACOD4 on 4q21, which is disrupted in a single twogeneration family with CL (89).
FUTURE DIRECTIONS
The completion of the genome sequence has contributed to recent successes in identifying novel CL/P genes. The direct study of non-syndromic CL/P has previously been hampered due to the general lack of well-defined multiplex families with sufficient power to enable a genome-wide linkage study to provide a localisation. The use of model organisms and in particular the mouse, has for some time been a rich source of information for craniofacial development. Transgenic and knockout technology has often, and sometimes quite unexpectedly, provided a long list of genes that confer an CL/P phenotype. The number and diversity of targeted genes that result in a cleft probably reflects why CL/P is one of the most common features seen in human birth defects. The use of mutant inbred strains to tease out causative genes and provide models is an exceptionally powerful tool. Nevertheless, the problem is to directly relate them to the complex human situation where genetic heterogeneity and varying environmental/socio-economic status is found. Our general failure to pinpoint the precise molecular events that lead to human CL/P most likely stems from our lack of knowledge about the gene networks and regulation of gene expression during palatal development. Clearly we are now in a far better position to address this. We now have several genes that play strong genetic roles in human craniofacial development and contribute to the incidence of non-syndromic CL/P. These genes will provide tools to study and elucidate the genetic pathways that they function in. This can be combined with a second powerful approach, using the latest generation of expression profiling techniques. In conjunction with the genome sequence and virtually a complete list of genes, detailed information about the genes that are expressed and those that are switched on or off at different stages of craniofacial development can be determined. Recent examples of this are the ongoing studies of COGENE (http://hg.wustl.edu/COGENE/), where expression profiling using both microarray and SAGE technologies are being used to generate profiles of a variety of human orofacial structures between 4 and 8.5 weeks of development. Similarly, a recent study from Brown et al. (90) used microarray analysis to look at expression profiles of mouse vertical, horizontal and fused (E13.5, 14.5 and 15.5) palatal shelves. An alternative approach has been reported by Fowles et al. (91) who performed a subtractive hydbridization screen to enrich for E10.5 mouse embryonic branchial arches 1-and 2-specific genes. The validity of this approach was demonstrated by identifying a variety of genes with established roles in craniofacial development in a random sampling.
There is now every reason to be optimistic about our future understanding of human CL/P. Whilst syndromic gene mutations may contribute no more than 10% to non-syndromic CL/P, these findings will lead to a better understanding of the gene pathways, interactions and novel candidates. For many, the benefits of precise diagnosis, accurate risk assessment and genetic counselling can be achieved. When integrated with tissue specific expression profiling and targeted developmental studies, the potential for treatments and preventative therapies may also become a reality.
